Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 1, 2009, Pages 74-78

  Hanif, M ^a   Malik, S ^a   Dhingra, V K ^a  

^a New Delhi Tuberculosis Centre   (India)

Author keywords

Drug resistance; Previously treated; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; HEALTH CENTER; HUMAN; INDIA; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TREATMENT FAILURE;

DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, MICROBIAL; HOSPITALS, CHRONIC DISEASE; HUMANS; INDIA; PREVALENCE; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 58149389759     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. A training course on managing the Revised National Tuberculosis Programme in your area. New Delhi, India: Central TB Division, 2005.
2. Parmasivan C N, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004; 120: 377-386.
3. Migliori G B, Espinal M, Danilova I D, Punga V V, Grzemska M, Raviglione M C. Frequency of recurrence among MDR-TB cases successfully treated with standardised short course chemotherapy. Int J Tuberc Lung Dis 2002; 6: 858-864.
4. World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Record 2006; 81: 430-432.
5. Jain N K, Chopra K K, Prasad G. Initial and acquired isoniazid and rifampicin resistance to M. tuberculosis and its implications for treatment. Indian J Tuberc 1992; 39: 121-124.
6. Janmeja A K, Raj B. Acquired drug resistance in tuberculosis in Haryana, India. J Assoc Physicians India 1998; 46: 194-198.
7. Mathur M L, Khatri P K, Base C S. Drug resistance in tuberculosis patients in Jodhpur District. Ind J Med Sci 2000; 54: 55-58.
8. Negi S S, Gupta S, Lal S. Drug resistance in tuberculosis in Delhi: a 2-year profile. J Commun Dis 2003; 35: 74-81.
9. Singla N, Sharma P P, Singla R, Jain R C. Survey of knowledge, attitudes and practices for tuberculosis among general practitioners in Delhi, India. Int J Tuberc Lung Dis 1998; 2: 384-389.
10. Government of India, National Tuberculosis Institute. Manual on isolation, identification and sensitivity testing of Mycobacterium tuberculosis. 2nd ed. Bangalore, India: National Tuberculosis Institute, 1998.
11. Kent P T, Kubica G P. Public health mycobacteriology. A guide for the level III laboratory. Atlanta, GA, USA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1985: pp 96-103.
12. Salaniponi F M, Nyirendra T E, Kemp J R, Squire S B, Godfrey-Faussett P, Harries A D. Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. Int J Tuberc Lung Dis 2003; 7: 948-952.
13. Shah A R, Agarwal S K, Shah K V. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc Lung Dis 2002; 6: 1098-1101.
14. Vijay S, Bala Sangameshwara V H, Jagannatha P S, Kumar P. Initial drug resistance among tuberculosis patients under DOTS Programme in Bangalore City. Indian J Tuberc 2004; 51: 17-21.
15. Dam T, Isa M, Bose M. Drug sensitivity profile of Mycobacterium tuberculosis isolates - a retrospective study from a chest disease institute in India. J Med Microbiol 2005; 54: 269-271.
16. Quy H T, Lan N T, Borgdorff M W, et al. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis 2003; 7: 631-636.
17. Chavez Pachas A M, Blank R, Smith Fawzi M C, Bayona J, Becerra M C, Mitnick C D. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int J Tuberc Lung Dis 2004; 8: 52-58.
18. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. DOTS-Plus guidelines. New Delhi, India: Directorate General of Health Services, 2008.